The short answer

Yes, iron deficiency can develop on a GLP-1 medication, but it is uncommon and the drug is rarely the whole story. In the largest records study to date, iron-deficiency anemia was diagnosed in 1.6% of users at six months and 3.2% at twelve months, a rate that was not meaningfully higher than in people taking metformin alone. The more interesting signal is mechanical: a small pilot found semaglutide measurably cut how much iron the gut absorbed. That makes iron worth watching, especially if you already run low.

Can GLP-1 medications cause iron deficiency?

Iron deficiency is the most common nutrient shortage in the world, so the real question is whether a GLP-1 drug makes it more likely. The honest answer from the data is: a little, maybe, and less than the headlines imply. The best numbers come from a review published in Nutrients in June 2026 that pulled together the evidence on iron and incretin-based therapies.

The anchor figure is a claims analysis of 461,382 adults (reported by Butsch and colleagues) who newly started a GLP-1 receptor agonist and had no prior nutritional deficiency. Most were on dulaglutide, semaglutide (the molecule in Ozempic and Wegovy) or liraglutide. Iron-deficiency anemia was diagnosed in 1.6% of them at six months and 3.2% at twelve months. Those are small numbers, and they grew over the first year rather than appearing overnight.

Here is the part that keeps this honest. When the same analysis compared GLP-1 users against people taking only metformin, the iron-deficiency-anemia rates were almost identical: 1.5% versus 1.4% at six months, with no statistically significant difference. So the modest climb in iron problems may track with having type 2 diabetes and losing weight, not with the GLP-1 drug specifically. A separate analysis summarized in the review found hemoglobin fell by a median of just 0.2 g/dL over about nine months, with 8.4% of patients developing anemia. These are real but gentle shifts, not a collapse.

Why iron can fall on a GLP-1 drug

Two forces push in the same direction on these medications. The first is obvious once you have taken one: you eat less. GLP-1 drugs blunt appetite, and the foods people quietly drop (red meat, in particular) are often the richest sources of iron. A narrower, more monotonous diet means less iron going in. Add the GLP-1 side effects that hit the gut, like nausea, vomiting and reduced food intake, and the shortfall widens.

The second force is less obvious: the same drugs may reduce how much iron your gut pulls from food. GLP-1 medications slow gastric emptying and calm the small intestine, which changes the timing and efficiency of nutrient absorption. A prospective pilot study (Melis and colleagues) put this to a direct test in 51 adults with type 2 diabetes who started once-weekly semaglutide. The researchers measured iron uptake from a standard iron capsule before treatment and again at ten weeks. Iron absorption fell by a median of 13% after semaglutide started, and 17.6% of participants (9 of 51) saw their absorption drop by at least 30%. The study is small and early, but it points to a real mechanism rather than just "people eat less."

This is the same pattern Shield keeps finding across micronutrients: the medicine works by quieting hunger and slowing the gut, and those two actions have knock-on effects on what reaches your bloodstream. Iron is simply one of the clearer examples. Our overview of how nutrient deficiencies on GLP-1 nearly double between month 6 and month 12 sets iron in that wider context.

How to tell if your iron is low

Low iron is sneaky because its early signs look like ordinary life on a GLP-1 drug. Fatigue, breathlessness on stairs, cold hands, brittle nails, hair thinning and brain fog can all come from falling iron, and all of them are easy to blame on eating less or losing weight. That overlap is exactly why you test rather than guess.

Two blood tests do most of the work. Serum ferritin reflects your iron stores and is the first-line check: a level below 30 ng/mL signals iron deficiency. Transferrin saturation (TSAT) shows how much iron is actually circulating and available; below 20% is the deficiency threshold. Iron-deficiency anemia is diagnosed when those iron markers are low and hemoglobin drops below the normal range, under 12 g/dL in women. One caveat worth knowing: ferritin rises with inflammation, so if you have an infection or an inflammatory condition, your doctor reads ferritin and TSAT together rather than trusting ferritin alone.

Iron is not the only thing that slides on these drugs, and the symptoms rhyme. Low vitamin B12 and semaglutide use can both leave you tired and foggy, which is one reason a sensible check looks at iron, vitamin B12 and folate together rather than chasing one number. If you want the full panel, our monitoring guide for vitamins on GLP-1 lays out what to ask for and when.

How to protect your iron on GLP-1

You do not need to fear iron deficiency on a GLP-1 drug, but you do need a plan, because food alone can be a tight budget when you are eating far less. The review lays out a practical, food-first approach that you can take to your own clinician.

  • Prioritise iron-dense foods. Heme iron from meat, poultry and fish absorbs far better than the non-heme iron in plants, so a small portion of lean red meat goes a long way when your total intake is low.
  • Pair iron with vitamin C. Vitamin C converts plant iron into a form your gut absorbs more readily. Eating iron-rich foods alongside citrus, bell peppers, tomatoes, berries or leafy greens meaningfully boosts uptake. If you take an oral iron supplement, a 500 mg/day vitamin C dose can be added to help it work.
  • Mind the blockers and the timing. Calcium, tea and coffee all cut iron absorption, so keep them at least an hour away from an iron supplement or an iron-rich meal. If you take a multivitamin with calcium, separate it from your iron.
  • Fix a known deficiency before you start. If you are already iron-deficient, the review advises starting or intensifying iron repletion before beginning a GLP-1 drug, not after, because absorption only gets harder once the medication is on board.
  • Know when pills are not enough. Intravenous iron is reserved for people who need faster repletion than tablets can give, who cannot tolerate oral iron, or who have ongoing blood loss. After IV iron, your blood count and iron markers should be rechecked around four weeks later.

A word of caution that matters here: more iron is not automatically better. Iron supplements can harm people who carry too much iron, so this is a test-first, treat-to-target decision made with your clinician, not a supplement to add on a hunch. That measured, repletion-not-megadose approach is exactly what GLP-1 Shield is built around. Supplements do not treat or prevent disease, and they are no substitute for medical care, but closing a genuine gap before it becomes anemia is the point. For the broader picture of what tends to run low, see which vitamins you are most likely deficient in on GLP-1 medications.

Key takeaways

  • Iron-deficiency anemia on GLP-1 medications is real but uncommon: 1.6% of users at six months and 3.2% at twelve months in a 461,382-person analysis.
  • That rate was not meaningfully higher than in people on metformin alone (1.5% versus 1.4% at six months), so the drug is likely not the sole cause.
  • A 51-person pilot found semaglutide cut iron absorption by a median of 13%, pointing to a genuine mechanism on top of simply eating less.
  • Check serum ferritin (deficiency below 30 ng/mL) and transferrin saturation (below 20%), and look at iron, vitamin B12 and folate together.
  • Protect iron with heme-rich foods plus vitamin C, keep calcium and coffee away from iron, and treat a known deficiency before starting a GLP-1 drug, always under clinician guidance.

Worried about your own nutrient gaps on GLP-1?

Be among the first to try the scientifically designed GLP-1 Shield supplements.

Frequently asked questions

Can Ozempic cause iron deficiency or anemia?
Iron deficiency can develop on Ozempic or other GLP-1 drugs, but it is uncommon. In a 461,382-person analysis, iron-deficiency anemia was diagnosed in 1.6% of GLP-1 users at six months and 3.2% at twelve months, a rate that was not significantly higher than in people on metformin alone. The likely drivers are eating less and, per a small pilot, slightly reduced iron absorption.
Why do I feel so tired on Ozempic, and could it be low iron?
Fatigue on Ozempic is common and usually comes from eating far less and losing weight quickly, but low iron can be part of it. Iron deficiency causes tiredness, breathlessness and brain fog, which overlap with ordinary GLP-1 effects. The only way to know is a blood test for ferritin and transferrin saturation, ideally checked alongside vitamin B12 and folate.
What iron level is too low on a GLP-1 drug?
Iron deficiency is generally defined as a serum ferritin below 30 ng/mL or a transferrin saturation below 20%. Iron-deficiency anemia adds a low hemoglobin, under 12 g/dL in women. Because ferritin rises with inflammation, a clinician reads it together with transferrin saturation rather than relying on ferritin alone.
Should I take an iron supplement while on semaglutide?
Only if testing shows you need it. Iron supplements can harm people who already carry too much iron, so this is a test-first decision made with your clinician. If you are deficient, taking iron with 500 mg of vitamin C and keeping calcium, tea and coffee at least an hour away improves absorption, which matters more when a GLP-1 drug is slowing your gut.

Sources

  1. Infante M, Ricordi C, Pacifici F, Pastore D, Infante R, Caprio M, et al. Ironing out possible micronutrient deficiencies associated with incretin receptor agonist-based therapies: proposed practical strategies to prevent and manage iron deficiency. Nutrients. 2026;18(13):2038. https://pmc.ncbi.nlm.nih.gov/articles/PMC13362726/